Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tango Therapeutics Inc (NQ: TNGX ) 9.750 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 9.750 Bid (Size) 7.250 (2) Ask (Size) 15.50 (1) Prev. Close 9.750 Today's Range 9.750 - 9.750 52wk Range 3.050 - 13.03 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Expert Outlook: Tango Therapeutics Through The Eyes Of 6 Analysts July 09, 2024 Via Benzinga Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference June 05, 2024 From Tango Therapeutics, Inc. Via Business Wire Performance YTD -2.30% -2.30% 1 Month +13.64% +13.64% 3 Month +23.89% +23.89% 6 Month -21.31% -21.31% 1 Year +188.46% +188.46% More News Read More Forecasting The Future: 4 Analyst Projections For Tango Therapeutics May 24, 2024 Via Benzinga Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity May 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 23, 2024 Via Benzinga Recap: Tango Therapeutics Q4 Earnings March 18, 2024 Via Benzinga Tango Therapeutics: Q3 Earnings Insights November 08, 2023 Via Benzinga Tango Therapeutics Announces Discontinuation of TNG348 Program May 23, 2024 From Tango Therapeutics Via Business Wire TNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights May 08, 2024 From Tango Therapeutics, Inc. Via Business Wire Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 01, 2024 From Tango Therapeutics, Inc. Via Business Wire TNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q4 2023 March 18, 2024 Via InvestorPlace Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights March 18, 2024 From Tango Therapeutics, Inc. Via Business Wire Tango Therapeutics to Participate in Upcoming Investor Conferences March 06, 2024 From Tango Therapeutics, Inc. Via Business Wire Pancreatic Cancer Treatments Poised for Major Advances in 2024 February 07, 2024 Via FinancialNewsMedia Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday October 17, 2023 Via Benzinga Topics Stocks Exposures US Equities Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session October 16, 2023 Via Benzinga Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session October 13, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 09, 2023 Via Benzinga Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session October 12, 2023 Via Benzinga Why Shares of Tango Therapeutics Are Dropping Monday October 09, 2023 Via The Motley Fool Chart Of The Day: Tango Therapeutics - What Happens When The FDA Gives A Thumbs UP! October 06, 2023 Via Talk Markets Exposures Product Safety Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session October 09, 2023 Via Benzinga Why Shares of Tango Therapeutics Climbed This Week September 14, 2023 Via The Motley Fool Exposures Product Safety Oracle, Sight Sciences And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session September 12, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
